Michael Greiner - 04 Mar 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Interim CEO
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
04 Mar 2025
Net transactions value
-$161,740
Form type
4
Filing time
06 Mar 2025, 14:22:40 UTC
Previous filing
05 Dec 2024
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Options Exercise $0 +12,149 +6% $0.000000 214,235 04 Mar 2025 Direct F1, F2
transaction AVNS Common Stock Tax liability $91,506 -6,048 -2.8% $15.13 208,187 04 Mar 2025 Direct F3
transaction AVNS Common Stock Tax liability $70,233 -4,642 -2.2% $15.13 203,545 04 Mar 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2 Total beneficially owned includes 666 shares acquired on December 31, 2024 and 522 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 12,149 PRSUs which vested on March 4, 2025.
F4 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 10,396 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.